Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2008
12/18/2008WO2008154563A1 1, 3 - dihydroxy substituted phenylamide glucokinase activators
12/18/2008WO2008154246A1 Hiv integrase inhibitors
12/18/2008WO2008154241A1 5-heteroaryl substituted indazoles as kinase inhibitors
12/18/2008WO2008153858A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008WO2008153091A1 Screening method
12/18/2008WO2008153042A1 Anti-tumor agent
12/18/2008WO2008152418A1 Piperidine compounds and uses thereof
12/18/2008WO2008152332A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/18/2008WO2008152223A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/18/2008WO2008152097A1 Cinnamic acid derivatives as modulators of the ep2 receptor
12/18/2008WO2008152094A2 Substituted acetamides as modulators of the ep2 receptor
12/18/2008WO2008152093A2 Diaminopyrimidines as modulators of the ep2 receptor
12/18/2008WO2008152073A2 Piperazine compounds with a herbicidal action
12/18/2008WO2008152014A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
12/18/2008WO2008151828A2 Novel microbiocides
12/18/2008WO2008131000A3 7-substituted indole mcl-1 inhibitors
12/18/2008WO2008130321A3 Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
12/18/2008WO2008116139A3 N-heterocyclic compounds useful as inhibitors of janus kinases
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008WO2008100457A3 Functionally selective alpha2c adrenoreceptor agonists
12/18/2008US20080312438 -(2-Aminopyrid-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for immunoglobulins IgE and IgG antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis
12/18/2008US20080312436 Colorless Water-Soluble Organic Luminophores and Intermediates Thereof
12/18/2008US20080312435 Imine Compound
12/18/2008US20080312300 Processes for the Preparation of Stable Polymorphic Form I of Ritonavir
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312291 Heterocyclic Gaba-b Modulators
12/18/2008US20080312282 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme
12/18/2008US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity
12/18/2008US20080312255 Piperdine compounds and uses thereof-911
12/18/2008US20080312254 Process for the Preparation of Ziprasidone
12/18/2008US20080312226 Amide Compound
12/18/2008US20080312223 Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora Kinases
12/18/2008US20080312222 4-Benzyledene-Piperidin Derivatives
12/18/2008US20080312221 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/18/2008US20080312220 Oxadiazole Derivatives with Crth2 Receptor Activity
12/18/2008US20080312209 Piperazine Heteroaryl Derivatives as Gpr38 Agonists
12/18/2008US20080312207 Compounds
12/18/2008US20080312206 Chemical Compounds-149
12/18/2008US20080312085 Pesticidal Compositions
12/18/2008US20080311076 Morpholinylanilinoquinazoline Derivatives For Use As Antiviral Agents
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008DE102007005045B4 Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Phenothiazine derivatives, processes for their preparation and their use as medicaments
12/18/2008CA2694860A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008CA2691987A1 Antibacterial agents
12/18/2008CA2690567A1 New compounds
12/18/2008CA2689209A1 Piperazine compounds having herbicidal action
12/18/2008CA2689117A1 5-heteroaryl substituted indazoles as kinase inhibitors
12/18/2008CA2689076A1 Piperidine compounds and uses thereof
12/18/2008CA2688343A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
12/18/2008CA2688237A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/18/2008CA2685402A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/17/2008EP2003132A1 Hetero compound
12/17/2008EP2003119A1 Substituted acetamides as modulators of EP2 receptors
12/17/2008EP2003118A1 Cinnamic acid derivatives as modulators of EP2 receptors
12/17/2008EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/17/2008EP2001875A2 Glucokinase activators
12/17/2008EP2001873A1 Active ingredient combinations with insecticidal properties
12/17/2008EP2001844A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/17/2008EP2001298A2 Substituted 5-hetaryl-4-aminopyrimidines
12/17/2008EP1819695B1 Anthranilamide derivatives as insecticides
12/17/2008EP1753736B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/17/2008EP1684744A4 Pyrrolidine and piperidine derivatives as factor xa inhibitors
12/17/2008EP1417176B1 Substituted anthranilamides for controlling invertebrate pests
12/17/2008CN101326180A Piperazine derivative renin inhibitors
12/17/2008CN101326177A Dihydroisoindolones as allosteric modulators of glucokinase
12/17/2008CN101326173A Thiadiazoles derivant as anti-diabetes agent
12/17/2008CN101326171A Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders
12/17/2008CN101326167A Pyridiazinone derivatives for tumour treatment
12/17/2008CN101323601A Triazole derivatives useful in therapy
12/17/2008CN100443483C Condensed ring unit terminated oligomerized thiophen analog high mobility organic semi-conducting material and its uses
12/17/2008CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands
12/17/2008CN100443477C Substituted benzoxazoles and analogues as estrogenic agents
12/17/2008CN100443474C New pyridazin-3(2h)-one derivatives
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/16/2008US7465801 Process to prepare pioglitazone via several novel intermediates
12/16/2008US7465750 Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods
12/16/2008US7465746 Fluorinated 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP
12/16/2008US7465744 Triazole compounds and the therapeutic use thereof
12/16/2008US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases
12/16/2008US7465732 (2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives
12/16/2008US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
12/16/2008US7465726 Substituted pyrrolo[2.3-B]pyridines
12/16/2008US7465725 e.g. N-{2-[3-(3,4-dimethoxy-phenyl)-propyl]-6-morpholin-4-yl-pyrimidin-4-yl}-N'-(1H-indol-3-ylmethylene)-hydrazine; interleukin-12 antagonist; antiinflammatory, antidiabetic agent; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
12/16/2008US7465721 N-(10H-phenothiazin-2-ylcarbonyl)-L-leucyl-L-leucyl-N1-[(3 S)-2-methoxytetrahydrofuran-3-yl]-L-leucinamide; calpain (proteolytic enzyme) inhibitor; traps the reactive oxygen species ; antiinflammatory, antiproliferative agent, autoimmune diseases
12/16/2008US7465718 Ansamycins having improved pharmacological and biological properties
12/11/2008WO2008150217A1 2-amino-5, 5-diaryl-imidazol-4-one analogs for the inhibition of beta-secretase
12/11/2008WO2008150015A1 Heterobicyclic compounds as kinase inhibitors
12/11/2008WO2008149110A1 Bicyclor [2.2.1] hept-7-ylamine derivatives and their use in the treatment of diseases and conditions in which m3 muscarinic receptor activity and beta-adrenergic activity are implicated
12/11/2008WO2008148832A1 Compounds which potentiate ampa receptor and uses therof in medicine
12/11/2008WO2008148302A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
12/11/2008WO2008130953A3 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
12/11/2008WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety
12/11/2008WO2008073451A8 Benzoimidazole derivatives as sirtuin (sir) modulating compounds
12/11/2008WO2008028032A3 Therapeutic substituted hydantoins and related compounds
12/11/2008WO2007096618A3 2-[3h-thiazol-2-ylidinemethyl]pyridines and related compounds and their use
12/11/2008WO2007061661A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306121 Bisheterocycle Tandem Compounds Useful as Antiviral Agents, the Uses Thereof and the Compositions Comprising Such Compounds
12/11/2008US20080306114 Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Hyperglycemia and Related Disorders
12/11/2008US20080306101 Insecticidal Spironindane Derivatives